Vukovar, Croatia

Milan Cacic

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: I-Nova Medicinska Istrazivanja D.o.o.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Milan Cacic. Retrieved from https://idiyas.com/inventor/milan-cacic

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Milan Cacic: Innovator in Antiviral Pharmaceutical Composition

Introduction

Milan Cacic is a notable inventor based in Vukovar, Croatia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral agents. His innovative work focuses on the synthesis and application of coumarin derivatives.

Latest Patents

Cacic holds a patent for a coumarin derivative as an antiviral agent, which includes a pharmaceutical composition, its preparation, and use. The invention discloses a novel coumarin derivative of formula (1), detailing its synthesis and the pharmaceutical composition that incorporates this active ingredient. This composition is designed to be safe and effective for treating viral diseases, including acquired immunodeficiency syndrome (AIDS).

Career Highlights

Milan Cacic is associated with I-nova Medicinska Istrazivanja D.o.o., where he applies his expertise in pharmaceutical research. His work has led to advancements in therapeutic agents that address critical health issues.

Collaborations

Cacic collaborates with professionals such as Mladen Trkovnik and Jonuz Rizvani, contributing to a dynamic research environment that fosters innovation in pharmaceutical development.

Conclusion

Milan Cacic's contributions to antiviral pharmaceutical compositions highlight his role as a key innovator in the field. His work not only advances scientific knowledge but also has the potential to improve therapeutic options for viral diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…